This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kluth, B. Articles by Feucht, H. E. Search for Related Content PubMed PubMed Citation Articles by Kluth, B. Articles by Feucht, H. E.

Endothelial Expression of CD40 in Renal Cell Carcinoma¹

Institut für Immunologie [B. K., S. H., H. E., S. S., G. R., H. E. F.] and Medizinische Klinik, Klinikum Innenstadt [H. E. F.], Ludwig-Maximilians-Universität München, Ziemssenstrasse I. D-80336 München, Germany

Recently, the immunoregulative molecule CD40 has also been introduced as a potential surface determinant of endothelial cells that can be induced by various cytokines and thus might be involved in inflammatory vascular reactions. In this study, the ubiquitous endothelial expression of CD40 within the neovascularized areas of renal cell carcinoma is demonstrated. The strong capillary expression of CD40 in 12 tumor samples is contrasted by the absence of endothelial CD40 in the corresponding tumor-free kidney specimens in which only certain tubular segments and few interstitial cells carry CD40. Northern hybridization studies confirmed the presence of CD40 RNA in cytokine-treated endothelial cells and in renal cell carcinoma, whereas no hybridization signal was obtained with normal kidney tissue. That the presence of tumor cells is pertinent to the endothelial expression of CD40 could be substantiated by in vitro experiments, when a renal carcinoma cell line and its supernatant, but not normal kidney cells, could induce CD40 on endothelial cells in culture. According to further experimental results, the carcinoma-derived, CD40-inducing factor(s) is not represented within a variety of pleiotropic cytokines including IFN-, interleukin 1, interleukin 6, and tumor necrosis factor , or common angiogenic factors such as basic fibroblast growth factor, vascular endothelial cell growth factor, angiogenin, and erythropoietin. The immunohistological results showing a widespread, even distribution of CD40 in tumor capillaries suggest that within renal cell carcinoma, the appearance of endothelial CD40 may also be related to angiogenesis in addition to inflammation.

¹ This study was supported by the Deutsche Forschungsgemeinschaft (SFB 217:C8 and the Gerhard Hess Program). S. H. is recipient of a postdoctoral fellowship from the Boehringer Ingelheim Fonds. H. E. F. is the recipient of a Hermann and Lilly Schilling professorship. Publication of figures in color was made possible by a grant from Janssen-Cilag GmbH, Neuss, Germany.

² To whom correspondence should be addressed. Phone: 49-89/5160-2111; Fax: 49-89/5160-4428; E-mail: feucht@ifi.med.uni-muenchen.de.

Received 11/27/96. Accepted 1/ 6/97.

This article has been cited by other articles:

				S. Bergmann and P. P. Pandolfi Giving blood: a new role for CD40 in tumorigenesis J. Exp. Med., October 30, 2006; 203(11): 2409 - 2412. [Abstract] [Full Text] [PDF]

				H. Tsuzuki, H. Sunaga, T. Ito, N. Narita, C. Sugimoto, and S. Fujieda Reliability of Platelet-Derived Endothelial Cell Growth Factor as a Prognostic Factor for Oral and Oropharyngeal Carcinomas Arch Otolaryngol Head Neck Surg, December 1, 2005; 131(12): 1071 - 1078. [Abstract] [Full Text] [PDF]

				A. Ottaiano, A. De Chiara, F. Perrone, G. Botti, F. Fazioli, V. De Rosa, N. Mozzillo, V. Ravo, B. Morrica, C. Gallo, et al. Prognostic Value of CD40 in Adult Soft Tissue Sarcomas Clin. Cancer Res., April 15, 2004; 10(8): 2824 - 2831. [Abstract] [Full Text] [PDF]

				S. Russo, B. Bussolati, I. Deambrosis, F. Mariano, and G. Camussi Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction J. Immunol., November 15, 2003; 171(10): 5489 - 5497. [Abstract] [Full Text] [PDF]

				M. C. Deregibus, S. Buttiglieri, S. Russo, B. Bussolati, and G. Camussi CD40-dependent Activation of Phosphatidylinositol 3-Kinase/Akt Pathway Mediates Endothelial Cell Survival and in Vitro Angiogenesis J. Biol. Chem., May 9, 2003; 278(20): 18008 - 18014. [Abstract] [Full Text] [PDF]

				S. V. Jalukar, B. S. Hostager, and G. A. Bishop Characterization of the Roles of TNF Receptor-Associated Factor 6 in CD40-Mediated B Lymphocyte Effector Functions J. Immunol., January 15, 2000; 164(2): 623 - 630. [Abstract] [Full Text] [PDF]

				T. Bourcier, Magda De Saint-Jean, F. Brignole, A. Goguel, and C. Baudouin Expression of CD40 and CD40 Ligand in the Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 120 - 126. [Abstract] [Full Text]

				L. Biancone, V. Cantaluppi, M. Boccellino, L. Del Sorbo, S. Russo, A. Albini, I. Stamenkovic, and G. Camussi Activation of CD40 Favors the Growth and Vascularization of Kaposi's Sarcoma J. Immunol., December 1, 1999; 163(11): 6201 - 6208. [Abstract] [Full Text] [PDF]

				M. R. Posner, L. A. Cavacini, M. P. Upton, K. C. Tillman, E. R. Gornstein, and C. M. Norris Jr. Surface Membrane-expressed CD40 Is Present on Tumor Cells from Squamous Cell Cancer of the Head and Neck in Vitro and in Vivo and Regulates Cell Growth in Tumor Cell Lines Clin. Cancer Res., August 1, 1999; 5(8): 2261 - 2270. [Abstract] [Full Text] [PDF]

				H. Li and E. P. Nord CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2002; 282(6): F1020 - F1033. [Abstract] [Full Text] [PDF]